Peter Thiel-Backed Psychedelics Firm Buys Majority of Brain-Control Interface Firm

ATAI Life Sciences, a biosciences company backed by billionaire Peter Thiel that specializes in experimental treatment of mental disorders with psychedelic drugs, has bought out a majority stake in Psyber, which is working to meld the mind with machines.